Skip to main content

Site notifications

AusPAR: Pembrolizumab

Australian Public Assessment Report
Device/Product Name
Keytruda
Active ingredients
Pembrolizumab
AusPAR Date
Published
Submission Number
PM-2016–02736-1-4
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site